Posted by: fuadelhibri on: August 19, 2010
Trubion provides promising clinical-stage therapeutic candidates in the targeted disease areas of oncology and autoimmunity Trubion offers novel, protein therapeutic platforms and scientific expertise for developing innovative therapeutic candidates Transaction leverages large pharma partnerships to provide sales and marketing infrastructureidates Emergent reaffirms 2010 guidance for revenues and net income ROCKVILLE, Md., Aug 12, 2010 (BUSINESS [...]
Posted by: fuadelhibri on: August 17, 2009
Fuad El-Hibri has served as chief executive officer and as chairman of our board of directors since June 2004 and as president since March 2006. Mr. El-Hibri served as chief executive officer and chairman of the board of directors of BioPort Corporation from May 1998 until June 2004, when, as a result of our corporate [...]
